Goodwin

Contact
Share
Info
100 Northern Avenue
Boston, MA 02210, United States
Phone: 617.570.1000
Fax: 617.523.1231
Areas Of Practice
  • Antitrust & Trade Regulation
  • Appellate Practice
  • Art, Entertainment, & Sports Law
  • Class Action
  • Criminal Law
  • Energy & Utilities
  • Environmental Law
  • Finance & Banking
  • Government
  • Intellectual Property
  • International Law & Trade
  • Labor & Employment Law
  • Litigation
  • Privacy
  • Products Liability
  • Real Estate
  • Science, Computers, & Tech
  • Securities Law
  • Taxation
  • Toxic Torts
  • Transportation
  • Wills, Trusts, & Estate Planning
See more
Locations
Other U.S. Locations
  • California
  • D.C.
  • Massachusetts
  • New York
Other Countries
  • France
  • Germany
  • Hong Kong
  • United Kingdom
Number of Attorneys
1,000+ Attorneys

The Evolving Landscape of AI Regulation in Financial Services

Artificial intelligence (AI) is increasingly woven into financial services operations, transforming everything from consumer interactions through chatbots and targeted marketing to essential functions like underwriting, credit…more
 /  Consumer Protection, Finance & Banking, Science, Computers, & Technology

Third Circuit Holds That Granting Discovery Under Section 1782 Is Not a “Final” Judgment

The U.S. Court of Appeals for the Third Circuit recently issued an opinion holding that when a district court has ordered discovery under 28 U.S.C. § 1782, but has not yet conclusively defined the scope of that discovery, the…more
 /  Civil Procedure, Intellectual Property, International Law & Trade

Biosimilar Manufacturers to Expand Offerings in Europe and Japan

On June 9, 2025, biosimilar manufacturers Samsung Bioepis and Alvotech announced separate deals to expand their respective offerings in Japan and Europe…more
 /  Commercial Law & Contracts, International Law & Trade, Science, Computers, & Technology

Senate Banking Committee Proposes Bill That Would Eliminate CFPB Federal Reserve Funding

In June 2025, the Senate Banking Committee introduced a version of the “One Big, Beautiful Bill” that would eliminate the CFPB’s Federal Reserve funding. The CFPB can currently receive funds of up to 12% of the Federal…more
 /  Consumer Protection, Finance & Banking

When Can a Supplier Lawfully Restrict Active Sales in an Exclusive Distribution Agreement?

In its recent judgment in Beevers Kaas (Case C‑581/23), the European Court of Justice (ECJ) clarified how suppliers may validly restrict active sales in exclusive distribution arrangements under Article 4(b)(i) of the Vertical…more
 /  Antitrust & Trade Regulation, Commercial Law & Contracts, International Law & Trade

Oregon Governor Signs Law Aggressively Restricting Private Equity Investment in Medical Practices

*UPDATE* Oregon Senate Bill 951, described in the alert below originally published on May 30, 2025, was signed into law by Oregon Governor Tina Kotek on Monday, June 9, and will apply to all new investments beginning January 1,…more
 /  Business Organizations, Health, Mergers & Acquisitions

California’s AB 2013: Generative AI Developers Must Show Their Data

California Assembly Bill 2013 (AB 2013), known as the Generative Artificial Intelligence: Training Data Transparency Act, was signed into law on September 28, 2024, and is set to take effect on January 1, 2026…more
 /  Intellectual Property, Privacy, Science, Computers, & Technology

UK Employee Share Plans: 6th of July HMRC Reporting Deadline

Businesses that award shares, options or other securities to UK employees, directors or officer holders need to be aware of the July 6 deadline to submit an Employment Related Securities (ERS) annual return to HM Revenue &…more
 /  Business Organizations, Labor & Employment Law

UK Government announces update on new carried interest tax regime

On June 5, 2025, the UK Government announced the result of their recent consultation process regarding their plans to bring carried interest within the income tax regime from April 2026, subject to an effective tax rate of…more
 /  Finance & Banking, Taxation

Acting Comptroller of the Currency Discusses OCC’s Regulatory Agenda

In recent remarks delivered at the U.S. Chamber of Commerce Capital Markets Summit, Acting Comptroller of the Currency, Rodney E. Hood, outlined the OCC’s strategic priorities for building a resilient and revitalized federal…more
 /  Finance & Banking, Science, Computers, & Technology

FTC Files Proposed Order To Resolve Allegations of Purportedly Unlawful Student Loan Debt Relief Operation

On May 22, 2025, the FTC filed a proposed stipulated ord​er in the District Court for the Middle District of Florida to resolve allegations ​that several individuals ​and the student loan debt relief companies that they operated…more
 /  Consumer Protection, Finance & Banking

New Dental Industry Compliance Standards Take Shape: Dental Trade Alliance (DTA) Releases Revised Code of Ethics

On May 6, 2025, with almost no discernible press or public announcements, the Dental Trade Alliance (DTA) – a trade association of dental suppliers and service providers – issued a revised and restated U.S. Code of Ethics (the…more
 /  Commercial Law & Contracts, Health

Sandoz Launches PYZCHIVA® (Ustekinumab) Autoinjector in Europe

On May 21, 2025, Sandoz announced the commercial launch in Europe of its PYZCHIVA® (ustekinumab) autoinjector, “the first ustekinumab biosimilar in Europe commercially available in an autoinjector.”…more
 /  Commercial Law & Contracts, Science, Computers, & Technology

Samsung Bioepis Secures Marketing Approval in Korea for its Biosimilar to Amgen’s Bone Cancer Drug Xgeva

Samsung Bioepis Co., Ltd. has secured marketing approval in Korea for XBRYK, its biosimilar to Amgen’s bone cancer drug XGEVA, used to prevent fractures in those with bone metastases from solid tumors or multiple myeloma and to…more
 /  Health, International Law & Trade

State Drug Transparency Laws - 2025 Update

We previously reported on an uptick in the passage of state drug price transparency legislation. What follows is an update to that report. As of April 2025, approximately 23 states had passed drug price transparency laws…more
 /  Administrative Law, Consumer Protection, Health
Showing 1-15 of 1000 Results
/
View per page
Page: of 67
This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide